3-(2,4-Dichlorbenzamido)-4-ethoxy-N-hydroxybenzamide

ID: ALA4867041

PubChem CID: 164621437

Max Phase: Preclinical

Molecular Formula: C16H14Cl2N2O4

Molecular Weight: 369.20

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCOc1ccc(C(=O)NO)cc1NC(=O)c1ccc(Cl)cc1Cl

Standard InChI:  InChI=1S/C16H14Cl2N2O4/c1-2-24-14-6-3-9(15(21)20-23)7-13(14)19-16(22)11-5-4-10(17)8-12(11)18/h3-8,23H,2H2,1H3,(H,19,22)(H,20,21)

Standard InChI Key:  JAYJCKDEPAKXQN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 24 25  0  0  0  0  0  0  0  0999 V2000
   11.7984  -26.3746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7972  -27.2020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5120  -27.6148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2285  -27.2015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2256  -26.3709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5102  -25.9619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9385  -25.9558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6545  -26.3656    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9354  -25.1308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.3674  -25.9503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0819  -26.3637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7942  -25.9491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7916  -25.1232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0706  -24.7137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3611  -25.1305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5101  -26.3592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5128  -27.1842    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.2232  -25.9444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9390  -26.3546    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6435  -24.7234    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6371  -23.8986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9195  -23.4915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5078  -25.1369    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   11.0824  -27.6139    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  7  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 12 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 15 20  1  0
 20 21  1  0
 21 22  1  0
  6 23  1  0
  2 24  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4867041

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 369.20

Molecular Weight (Monoisotopic): 368.0331

AlogP: 3.76

#Rotatable Bonds: 5

Polar Surface Area: 87.66

Molecular Species: NEUTRAL

HBA: 4

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.20

CX Basic pKa: ┄

CX LogP: 3.32

CX LogD: 3.31

Aromatic Rings: 2

Heavy Atoms: 24

QED Weighted: 0.55

Np Likeness Score: -1.78

References

1. Ghazy E, Heimburg T, Lancelot J, Zeyen P, Schmidtkunz K, Truhn A, Darwish S, Simoben CV, Shaik TB, Erdmann F, Schmidt M, Robaa D, Romier C, Jung M, Pierce R, Sippl W..  (2021)  Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis.,  225  [PMID:34392190] [10.1016/j.ejmech.2021.113745]

Source

Source(1):

• Scientific Literature